Fractional exhaled nitric oxide as a biomarker for the evaluating asthmatic patients with allergic bronchopulmonary mycosis
{{output}}
Background: Fractional exhaled nitric oxide (FeNO) is a useful Type 2 biomarker for the diagnosis and management of asthma. Although allergic bronchopulmonary mycosis (ABPM) is an allergic disease characterized by Type 2 inflamma... ...
